EMILY REGEHR: Open Payments
NPI 1528493608 · ANDOVER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,606 in 109 payments from 22 companies in 2025. Trend: 2023 $1,041 · 2024 $1,467 · 2025 $1,606
Food & beverage: $1,606
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $203 |
| AstraZeneca Pharmaceuticals LP | 7 | $182 |
| ABBVIE INC. | 16 | $164 |
| GlaxoSmithKline, LLC. | 9 | $153 |
| Amgen Inc. | 11 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $137 |
| Lilly USA, LLC | 7 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Novo Nordisk Inc | 5 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
Products named: AIRSUPRA, NURTEC ODT, Kerendia, REXULTI, MOUNJARO, QULIPTA, OTEZLA, UBRELVY.
Industry payments across KS — which companies pay providers there.
